With the Federal Reserve signaling a possible rate hike to combat persistent inflation, the State Street Health Care Select Sector SPDR ETF stands out for its resilience and dividend profile during volatile market cycles
As the Federal Reserve considers another interest rate hike, investors seeking stability are focusing on the State Street Health Care Select Sector SPDR ETF (XLV). This fund has demonstrated resilience during turbulent markets, particularly when rising rates and inflation threaten returns in other sectors. With policymakers approaching a pivotal meeting, the central question extends beyond the likelihood of a rate increase to which sectors can help buffer portfolios against potential market fallout.
In 2023, U.S. health care sector ETFs attracted over $8 billion in net inflows, reflecting investor confidence in the sector's defensive qualities during periods of economic uncertainty.
Health Care's Defensive Edge
Health care stocks have long been viewed as a defensive option, and XLV's performance during the last tightening cycle reinforced this reputation. When the S&P 500 declined 18.6% during the 2022 rate hikes, XLV fell just 1.1%. The fund's $45 billion in assets are concentrated in large, established companies that typically sustain earnings even as borrowing costs rise and economic growth slows. Its top holdings-Eli Lilly, Johnson & Johnson, and AbbVie-are industry leaders and consistent dividend payers, with Johnson & Johnson among the select "Dividend Kings" that have increased payouts for over 50 consecutive years.
Dividend income can help cushion market volatility, and XLV's 30-day SEC yield recently stood at 1.47%. While this yield is modest compared to riskier assets, it reflects the fund's emphasis on stability and quality. The ETF's expense ratio of 0.08% also helps keep costs low for investors seeking long-term sector exposure.
Inflation and Rate Hike Dynamics
The interplay between inflation and interest rates is central to XLV's current appeal. Core PCE, which excludes volatile food and energy prices, is the Federal Open Market Committee's preferred inflation measure. As this metric rises, the Fed faces increased pressure to tighten policy, even if headline inflation appears to moderate. Rate hikes are intended to cool demand and slow price increases, but their effects often take months to work through the economy.
According to a 2023 analysis by S&P Dow Jones Indices, health care sector ETFs outperformed the broader market during the last three major Fed tightening cycles, with lower drawdowns and faster recoveries compared to most other sectors.
Correlation Shifts and Portfolio Strategy
In recent years, the negative correlation between equities and 10-year Treasury yields has become more pronounced. When this relationship turns negative, as seen during periods of persistent inflation, defensive sectors like health care often outperform more cyclical industries. This "correlation conundrum" underscores the importance of sector selection for investors aiming to manage risk as monetary policy evolves.
XLV's structure-anchored by dividend-paying leaders and a low expense ratio-positions it as a practical tool for reducing portfolio volatility. While no ETF is immune to market downturns, the fund's historical performance during rate hikes and its focus on high-quality holdings make it a candidate for investors cautious about aggressive Fed action.
Understanding the role of sector ETFs like XLV requires recognizing how interest rates affect both stock and bond markets. As rates rise, borrowing becomes more expensive, which can pressure growth stocks and highly leveraged companies. Defensive sectors, by contrast, tend to be less sensitive to economic swings. For investors, the challenge is to balance the pursuit of yield and growth with the need for stability-especially when policy uncertainty is high and inflation remains persistent.
